Eli Lilly and Co
US.LLY
1,149.36
-10.24
-0.88%
Eli Lilly and Co
1,149.36
-10.24
-0.88%
Collector offline (last heartbeat: 19189s ago)
· 2026-09-04 20:02
Pre-market
1,150.65
-0.77%
After-hours
1,146.65
-0.24%
Overnight
1,158.00
-0.14%
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 14 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 79.21% -0.06pp
- Institutions
- 5,290 -14
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund61.57%
Public Company9.48%
Private Company3.03%
Government Pension Fund1.87%
Sovereign Wealth Fund1.37%
Hedge Fund0.93%
Family Office/Trust0.40%
Corporate Pension Plan0.20%
Individual/Insider0.17%
Other20.98%
Top holders
| Holder | Stake |
|---|---|
| BlackRock | 7.58% |
| Vanguard Capital Management, LLC | 6.52% |
| The PNC Financial Services Group, Inc. | 5.74% |
| Capital Research | 4.82% |
| State Street Global Advisors | 4.06% |
| Other | 71.28% |
Insiders
31 filings tracked · 5 buys · 5 sells
| Name | Role | Stake |
|---|---|---|
| David Ricks | Chairperson & CEO | 0.09% |
| Daniel Skovronsky | EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology | 0.03% |
| Anne White | EVP & President of Lilly Neuroscience | 0.01% |
| Patrik Jonsson | EVP, Chief Customer Officer, President of Lilly Diabetes & Obesity and President Lilly USA | 0.01% |
| Anat Hakim | General Counsel | 0.01% |
| Edgardo Hernandez | EVP & President of Manufacturing Operations | 0.01% |
| Anat Ashkenazi | Chief Financial Officer | 0.00% |
| Jacob Van Naarden | EVP, CEO of Loxo Oncology & President of Lilly Oncology | 0.00% |
| Ilya Yuffa | EVP & President of Lilly International | 0.00% |
| Diogo Rau | EVP & Chief Information and Digital Officer | 0.00% |
Quote time 2026-09-04 20:02:22
For reference only, not investment advice.